Identification of drugs of Madhuraskandha of Charakasamhita
AbstractIn the classical text, Rasa oriented group of drugs were mentioned called as Rasaskandha. Acharya Sushruta, Vagbhata have mentioned these groups in the context of description of Rasa (Taste). But Acharya Charaka quoted these groups in Vimanasthana while describing drugs for Asthapana Basti (Corrective enema). Drugs having predominantly of Madhura rasa (sweet taste) and Vipaka (Final transformation of drug) or that can produce effect similar to that of Madhura Rasa or Vipaka (Prabhava- specific action) are included under Madhuraskandha. In total 85 drugs are mentioned. In this group 68 are identified, 14 are unidentified and 3 are found to be controversial drugs. Among them 56 drugs are Madhura rasa (sweet taste) dominant, 53 are Madhura vipaka (final transformation into sweet) dominant and 18 are categorized under Madhura prabhava (specific action). The drugs included in Madhuraskandha (group of the drugs having Sweet taste or potential), irrespective of Â Madhura Rasa or Vipaka, are capable of attributed to functions Madhura Rasa or Vipaka like Jeevaniya (invigorating), Preenana (soothing), Balya (promotes strength), Brihmana (nourishing), Rasayana (anti-ageing), Vrishya (aphrodisiac), Shukrala (promotes semen) etc.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.